Literature DB >> 22947062

Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban.

J Harenberg1, S Marx, C Weiss, R Krämer, M Samama, S Schulman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22947062     DOI: 10.1111/j.1538-7836.2012.04784.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  12 in total

Review 1.  Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

Review 2.  Monitoring target specific anticoagulants.

Authors:  Barbara A Konkle
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

Review 3.  Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitations.

Authors:  Helen Mani; Alexander Kasper; Edelgard Lindhoff-Last
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

4.  Laboratory tests during direct oral anticoagulant treatment? No.

Authors:  Giovanni Di Minno; Elena Ricciardi; Antonella Scalera
Journal:  Intern Emerg Med       Date:  2013-05-21       Impact factor: 3.397

5.  Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report.

Authors:  Luca Masotti; Gianni Lorenzini; Cristiana Seravalle; Grazia Panigada; Giancarlo Landini; Roberto Cappelli; Sam Schulman
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

Review 6.  Rivaroxaban: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Authors:  Natalie J Carter; Greg L Plosker
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

7.  Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.

Authors:  Robert Ploen; Li Sun; Wei Zhou; Stefan Heitmeier; Markus Zorn; Ekkehart Jenetzky; Roland Veltkamp
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-18       Impact factor: 6.200

8.  Laboratory assessment of rivaroxaban: a review.

Authors:  Meyer Michel Samama; Geneviève Contant; Theodore E Spiro; Elisabeth Perzborn; Lena Le Flem; Céline Guinet; Yves Gourmelin; Gabriele Rohde; Jean-Luc Martinoli
Journal:  Thromb J       Date:  2013-07-03

Review 9.  Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants.

Authors:  Megan O Nakashima; Heesun J Rogers
Journal:  Blood Res       Date:  2014-06-25

10.  Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs.

Authors:  Raul Altman; Claudio Daniel Gonzalez
Journal:  Thromb J       Date:  2014-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.